Nelson, Van Denburg & Campbell Wealth Management Group, LLC Ascendis Pharma A/S Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.53 Billion
- Q1 2025
A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 7,561 shares of ASND stock, worth $1.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,561
Previous 7,561
-0.0%
Holding current value
$1.2 Million
Previous $1.04 Million
13.27%
% of portfolio
0.05%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding ASND
# of Institutions
270Shares Held
61.9MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.64 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$873 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$831 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$715 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$678 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.89B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...